Olema Oncology Announces Upcoming Poster Presentation at ESMO 2023
SAN FRANCISCO, May 8, 2023 (GLOBE NEWSWIRE) — Olema Pharmaceuticals, Inc. ((“Olema” or “Olema Oncology, NASDAQ:OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development